Heart Failure POC & LOC Device Market Report: Trends, Forecast and Competitive Analysis to 2030

Heart Failure POC & LOC Device Market Report: Trends, Forecast and Competitive Analysis to 2030

Heart Failure POC & LOC Device Trends and Forecast

The future of the heart failure POC & LOC device market looks promising with opportunities in the clinics, hospitals, homes, assisted living healthcare facilities, and laboratories markets. The heart failure POC & LOC device market is expected to reach an estimated $0.3 billion by 2030 with a CAGR of 15.9% from 2024 to 2030. The major drivers for this market are miniaturization, lab-on-chip technology shows significant potential for enhancing disease diagnosis in terms of cost-efficiency, throughput, simplicity of operation, and analysis and research and development efforts directed at creating innovative assays based on lab-on-chip technology for cardiovascular disease diagnosis.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Heart Failure POC & LOC Device by Segment

The study includes a forecast for the global heart failure POC & LOC device by technology, test type, end use industry, and region.

Heart Failure POC & LOC Device Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Microfluidics
• Array-Based Systems
• Others

Heart Failure POC & LOC Device Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

• Proteomic Testing
• Metabolomic Testing
• Genomic Testing

Heart Failure POC & LOC Device Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Clinics
• Hospitals
• Home
• Assisted Living Healthcare Facilities
• Laborator
• Others

Heart Failure POC & LOC Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Heart Failure POC & LOC Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies heart failure POC & LOC device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the heart failure POC & LOC device companies profiled in this report include-

• Abbott
• Danahar
• Siemens Healthineers
•  F. Hoffmann-La Roche
• Quidel 
• bioMérieux 
• Trinity BiotechInstrumentation

Heart Failure POC & LOC Device Market Insights

Lucintel forecasts that microfluidics will remain the largest segment over the forecast period due to increasing worry regarding mortality and morbidity rates stemming from cardiovascular diseases.

Within this market, clinic will remain the largest segment due to outpatient clinics are increasingly employing point-of-care devices on a larger scale to achieve timely and accurate diagnoses, enabling well-informed treatment decisions for heart failure.

North America will remain the largest region over the forecast period due to major key players in the u.s. market are significantly contributing to substantial organic revenue growth in the global heart failure sector.

Features of the Heart Failure POC & LOC Device Market

Market Size Estimates: Heart failure POC & LOC device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Heart failure POC & LOC device market size by technology, test type, end use industry, and region in terms of value ($B).

Regional Analysis: Heart failure POC & LOC device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technology, test type, end use industry, and regions for the heart failure POC & LOC device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the heart failure POC & LOC device market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the heart failure POC & LOC device market size?

Answer: The global heart failure POC & LOC device market is expected to reach an estimated $0.3 billion by 2030.

Q2. What is the growth forecast for heart failure POC & LOC device market?

Answer: The global heart failure POC & LOC device market is expected to grow with a CAGR of 15.9% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the heart failure POC & LOC device market?

Answer: The major drivers for this market are miniaturization, lab-on-chip technology shows significant potential for enhancing disease diagnosis in terms of cost-efficiency, throughput, simplicity of operation, and analysis and research and development efforts directed at creating innovative assays based on lab-on-chip technology for cardiovascular disease diagnosis.

Q4. What are the major segments for heart failure POC & LOC device market?

Answer: The future of the heart failure POC & LOC device market looks promising with opportunities in the clinics, hospitals, homes, assisted living healthcare facilities, and laboratories markets.

Q5. Who are the key heart failure POC & LOC device market companies?

Answer: Some of the key heart failure POC & LOC device companies are as follows:

• Abbott
• Danahar
• Siemens Healthineers
•  F. Hoffmann-La Roche
• Quidel 
• bioMérieux 
• Trinity BiotechInstrumentation

Q6. Which heart failure POC & LOC device market segment will be the largest in future?

Answer: Lucintel forecasts that microfluidics will remain the largest segment over the forecast period due to increasing worry regarding mortality and morbidity rates stemming from cardiovascular diseases.

Q7. In heart failure POC & LOC device market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to major key players in the u.s. market are significantly contributing to substantial organic revenue growth in the global heart failure sector.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the heart failure POC & LOC device market by technology (microfluidics, array-based systems, and others), test type (proteomic testing, metabolomic testing, and genomic testing), end use industry (clinics, hospitals, home, assisted living healthcare facilities, laborator, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Please note: It will take 3 business days to deliver the report upon receipt the order.